Call 408.493.1800 | Fax 408.493.1801 | Toll Free 800.891.9699 (US Only) | Email: [email protected]

MMP-13 Inhibitor Screening Kit (Fluorometric)

For screening, studying and characterizing potential inhibitors of MMP-13
Catalog #: K2067
$495.00

Product Details

Cat # +Size K2067-100
Size 100 assays
Kit Summary BioVision’s MMP-13 Inhibitor Screening Assay Kit provides a quick, easy and sensitive assay for screening, studying and characterizing potential inhibitors of MMP-13. In this assay, MMP-13 hydrolyzes a FRET-based MMP-13 substrate and releases unquenched by the catalysis of fluorescent group, Mca, which is detected fluorometrically at Ex/Em = 325/393 nm. A potent, specific MMP-13 inhibitor is also included in the kit.
Detection Method Fluorescence (Ex/Em = 325/393 nm)
Species Reactivity Mammalian
Applications Screening or characterizing MMP-13 inhibitors.
Features & Benefits • A quick, easy and sensitive assay for screening, studying and characterizing potential inhibitors of MMP-13.
• A potent, specific MMP-13 inhibitor is also included in the kit.
Kit Components • MMP-13 Assay Buffer
• MMP-13 Substrate
• Recombinant MMP-13
• MMP-13 Inhibitor (2 mM)
Storage Conditions -20ºC
Shipping Conditions Gel Pack
USAGE For Research Use Only! Not For Use in Humans.

Details

Matrix metalloproteinase-13 (MMP-13; Collagenase-3) is a zinc-dependent endopeptidase family member that is capable of degrading many protein components of the extracellular matrix (ECM) including type II collagen in articular cartilage and bone. It is produced and secreted as a 60-kDa inactive, precursor form (proMMP-13), which is activated to a 48-kDa form by extracellular proteinases such as plasmin, MMP-2, MMP-3 and MMP-14. MMP-13 has wide substrate specificity, as it degrades collagen types (I-IV) but preferentially hydrolyzes type II collagen. Additionally, it cleaves other ECM molecules including fibronectin, aggrecan, osteonectin etc. MMP-13 plays a major role in ECM remodeling during fetal bone development, post-natal bone remodeling, tissue remodeling etc. It is overexpressed in numerous pathological conditions including rheumatoid arthritis, osteoarthritis, atherosclerosis, aortic aneurysms, cancer etc. Thus, developing and screening of selective MMP-13 inhibitors is under intensive investigation for therapeutic intervention. BioVision’s MMP-13 Inhibitor Screening Assay Kit provides a quick, easy and sensitive assay for screening, studying and characterizing potential inhibitors of MMP-13. In this assay, MMP-13 hydrolyzes a FRET-based MMP-13 substrate and releases unquenched by the catalysis of fluorescent group, Mca, which is detected fluorometrically at Ex/Em = 325/393 nm. A potent, specific MMP-13 inhibitor is also included in the kit.


Why buy BioVision Products?
Innovation
Affordability
Global Presence
Technical Support
BioVision aims to provide our customers innovative tools for accelerating drug discovery and biological research. BioVision offers >8,000 products including the most comprehensive array of assay kits for key targets in Metabolic pathways.
BioVision is committed to providing the highest quality products at a competitive price.
We have a broad network of global distributors who are ready to address your research needs and ensure fast delivery.
Our highly trained Technical Support team provides comprehensive product support and is dedicated to resolving your issues quickly and efficiently.